These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 19682740)
1. Combined delivery of heme oxygenase-1 gene and fibroblast growth factor-2 protein for therapeutic angiogenesis. Bhang SH; Kim JH; Yang HS; La WG; Lee TJ; Sun AY; Kim GH; Lee M; Kim BS Biomaterials; 2009 Oct; 30(31):6247-56. PubMed ID: 19682740 [TBL] [Abstract][Full Text] [Related]
2. Combined gene therapy with hypoxia-inducible factor-1α and heme oxygenase-1 for therapeutic angiogenesis. Bhang SH; Kim JH; Yang HS; La WG; Lee TJ; Kim GH; Kim HA; Lee M; Kim BS Tissue Eng Part A; 2011 Apr; 17(7-8):915-26. PubMed ID: 20979535 [TBL] [Abstract][Full Text] [Related]
3. Delivery of fibroblast growth factor 2 enhances the viability of cord blood-derived mesenchymal stem cells transplanted to ischemic limbs. Bhang SH; Lee TJ; La WG; Kim DI; Kim BS J Biosci Bioeng; 2011 May; 111(5):584-9. PubMed ID: 21388874 [TBL] [Abstract][Full Text] [Related]
4. Delivery of basic fibroblast growth factor using heparin-conjugated fibrin for therapeutic angiogenesis. Yang HS; Bhang SH; Hwang JW; Kim DI; Kim BS Tissue Eng Part A; 2010 Jun; 16(6):2113-9. PubMed ID: 20136400 [TBL] [Abstract][Full Text] [Related]
5. Genetically modified human placenta‑derived mesenchymal stem cells with FGF‑2 and PDGF‑BB enhance neovascularization in a model of hindlimb ischemia. Yin T; He S; Su C; Chen X; Zhang D; Wan Y; Ye T; Shen G; Wang Y; Shi H; Yang L; Wei Y Mol Med Rep; 2015 Oct; 12(4):5093-9. PubMed ID: 26239842 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of heme oxygenase 1 expression by small interfering RNA decreases orthotopic tumor growth in livers of mice. Sass G; Leukel P; Schmitz V; Raskopf E; Ocker M; Neureiter D; Meissnitzer M; Tasika E; Tannapfel A; Tiegs G Int J Cancer; 2008 Sep; 123(6):1269-77. PubMed ID: 18566988 [TBL] [Abstract][Full Text] [Related]
7. Targeted disruption of the Fgf2 gene does not affect vascular growth in the mouse ischemic hindlimb. Sullivan CJ; Doetschman T; Hoying JB J Appl Physiol (1985); 2002 Dec; 93(6):2009-17. PubMed ID: 12391121 [TBL] [Abstract][Full Text] [Related]
8. Facilitated angiogenesis induced by heme oxygenase-1 gene transfer in a rat model of hindlimb ischemia. Suzuki M; Iso-o N; Takeshita S; Tsukamoto K; Mori I; Sato T; Ohno M; Nagai R; Ishizaka N Biochem Biophys Res Commun; 2003 Feb; 302(1):138-43. PubMed ID: 12593860 [TBL] [Abstract][Full Text] [Related]
9. Enhancement of long-term angiogenic efficacy of adipose stem cells by delivery of FGF2. Lee TJ; Bhang SH; Yang HS; La WG; Yoon HH; Shin JY; Seong JY; Shin H; Kim BS Microvasc Res; 2012 Jul; 84(1):1-8. PubMed ID: 22546563 [TBL] [Abstract][Full Text] [Related]
10. Angiogenesis in ischemic tissue produced by spheroid grafting of human adipose-derived stromal cells. Bhang SH; Cho SW; La WG; Lee TJ; Yang HS; Sun AY; Baek SH; Rhie JW; Kim BS Biomaterials; 2011 Apr; 32(11):2734-47. PubMed ID: 21262528 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic Benefits and Adverse Effects of Combined Proangiogenic Gene Therapy in Mouse Critical Leg Ischemia. Lebas B; Galley J; Renaud-Gabardos E; Pujol F; Lenfant F; Garmy-Susini B; Chaufour X; Prats AC Ann Vasc Surg; 2017 Apr; 40():252-261. PubMed ID: 27903483 [TBL] [Abstract][Full Text] [Related]
12. Myocardial functional recovery after fibroblast growth factor 2 gene therapy as assessed by echocardiography and magnetic resonance imaging. Horvath KA; Doukas J; Lu CY; Belkind N; Greene R; Pierce GF; Fullerton DA Ann Thorac Surg; 2002 Aug; 74(2):481-6; discussion 487. PubMed ID: 12173832 [TBL] [Abstract][Full Text] [Related]
13. IRES-based vector coexpressing FGF2 and Cyr61 provides synergistic and safe therapeutics of lower limb ischemia. Rayssac A; Neveu C; Pucelle M; Van den Berghe L; Prado-Lourenco L; Arnal JF; Chaufour X; Prats AC Mol Ther; 2009 Dec; 17(12):2010-9. PubMed ID: 19738600 [TBL] [Abstract][Full Text] [Related]
14. Effects of combined mesenchymal stem cells and heme oxygenase-1 therapy on cardiac performance. Zeng B; Chen H; Zhu C; Ren X; Lin G; Cao F Eur J Cardiothorac Surg; 2008 Oct; 34(4):850-6. PubMed ID: 18640847 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic effect of human adipose-derived stromal cells cluster in rat hind-limb ischemia. Park IS; Kang JA; Kang J; Rhie JW; Kim SH Anat Rec (Hoboken); 2014 Dec; 297(12):2289-98. PubMed ID: 25066828 [TBL] [Abstract][Full Text] [Related]
17. Appropriate control of ex vivo gene therapy delivering basic fibroblast growth factor promotes successful and safe development of collateral vessels in rabbit model of hind limb ischemia. Ishii S; Koyama H; Miyata T; Nishikage S; Hamada H; Miyatake S; Shigematsu H J Vasc Surg; 2004 Mar; 39(3):629-38. PubMed ID: 14981459 [TBL] [Abstract][Full Text] [Related]
18. Combination of stromal-derived factor-1alpha and vascular endothelial growth factor gene-modified endothelial progenitor cells is more effective for ischemic neovascularization. Yu JX; Huang XF; Lv WM; Ye CS; Peng XZ; Zhang H; Xiao LB; Wang SM J Vasc Surg; 2009 Sep; 50(3):608-16. PubMed ID: 19595531 [TBL] [Abstract][Full Text] [Related]
20. CD151 promotes neovascularization and improves blood perfusion in a rat hind-limb ischemia model. Lan RF; Liu ZX; Liu XC; Song YE; Wang DW J Endovasc Ther; 2005 Aug; 12(4):469-78. PubMed ID: 16048379 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]